Filter
3082
Filtered Results: 3082
Text search:
antiretrovirals
Featured
Recommendations
241
New Publications
824
Language
Document type
No document type
2053
Studies & Reports
370
Guidelines
357
Manuals
91
Strategic & Response Plan
66
Fact sheets
56
Training Material
37
Infographics
28
Situation Updates
16
Brochures
3
Resource Platforms
2
Online Courses
2
App
1
Countries / Regions
South Africa
103
Kenya
94
India
84
Zambia
78
Tanzania
77
Global
76
Malawi
74
Ethiopia
66
Namibia
58
Nigeria
57
Uganda
56
Rwanda
53
Western and Central Europe
53
Africa
51
Nepal
47
Latin America and the Carribbean
47
Lesotho
42
Liberia
41
Zimbabwe
40
Ukraine
38
Eastern Europe
38
Myanmar / Burma
35
Venezuela
33
Mozambique
32
Ghana
31
Sierra Leone
30
Asia
26
Senegal
24
Indonesia
23
Botswana
21
Cambodia
20
Paraguay
20
Russia
20
Germany
17
Bangladesh
17
Burkina Faso
16
Argentina
16
Brazil
16
Philippines
15
Colombia
14
Congo, Democratic Republic of
14
South–East Asia Region
14
East and Southern Africa
13
Cameroon
12
Haiti
11
Eswatini/ Swaziland
11
El Salvador
10
Benin
9
Peru
9
Bolivia
9
West and Central Africa
8
Tajikistan
7
Albania
7
North Macedonia
6
Georgia
6
South Sudan
6
Pakistan
6
Syria
5
Middle East and North Africa
5
Guinea
4
Armenia
4
Eastern Europe and Central Asia
4
Moldova
4
Sudan
4
Angola
4
Ecuador
4
Thailand
3
Guinea-Bissau
3
Western Pacific Region
3
Southern Africa
3
Vietnam
3
Central African Republic
3
Somalia
3
Iran
2
Estonia
2
Afghanistan
2
Jordan
2
Yemen
2
Romania
2
Mali
2
Libya
2
Bhutan
2
Madagascar
2
Switzerland
1
Serbia
1
Gambia
1
China
1
Chile
1
Canada
1
Laos
1
Niger
1
Burundi
1
Qatar
1
Bulgaria
1
Italy
1
USA
1
Dominican Republic
1
Hungary
1
Saudi Arabia
1
North America
1
Uruguay
1
Turkmenistan
1
Jamaica
1
Belgium
1
Belarus
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Papua New Guinea
1
Sri Lanka
1
Djibouti
1
Egypt
1
Palestine
1
Poland
1
Iraq
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
1299
Clinical Guidelines
232
Women & Child Health
141
Public Health
83
Capacity Building
63
Key Resources
55
Pharmacy & Technologies
25
Annual Report MEDBOX
1
Toolboxes
HIV
895
TB
393
COVID-19
103
Pharmacy
74
Caregiver
55
Mental Health
51
Health Financing Toolbox
38
Refugee
35
AMR
34
Conflict
33
NTDs
28
Global Health Education
28
Ebola & Marburg
24
Disability
20
NCDs
20
Natural Hazards
12
Rapid Response
10
Polio
10
Malaria
8
Social Ethics
5
Planetary Health
3
Zika
2
Technical Update
Areas of Africa endemic for Buruli ulcer (BU), caused by Mycobacterium ulcerans, also have a high prevalence of human immunodeficiency virus (HIV), with adult prevalence rates between 1% and 5% (Maps). However, there is limited information on the prevalence of BU–HIV coinfection....
FOLLOW-UP TO THE 2011 POLITICAL DECLARATION ON HIV/AIDS: INTENSIFYING EFFORTS TO ELIMINATE HIV/AIDS | Reporting Period: January – December 2014
The information provided here can be used to understand the current situation, increase attention to preterm births in Rwanda and to inform dialogue and action among stakeholders. Data can be used to identify the most important risk factors to target and gaps in care in order to identify and impleme...
This document defines the framework for Malawi’s National HIV Programs. Considering public health benefits and risks, as well as funding and resource implications, deviations from these guidelines are not supported by the Ministry of Health.
The information provided here can be used to understand the current situation, increase attention to preterm births in Rwanda and to inform dialogue and action among stakeholders. Data can be used to identify the most important risk factors to target and gaps in care in order to identify and impleme...
The information provided here can be used to understand the current situation, increase attention to preterm births in Rwanda and to inform dialogue and action among stakeholders. Data can be used to identify the most important risk factors to target and gaps in care in order to identify and impleme...
The information provided here can be used to understand the current situation, increase attention to preterm births in Rwanda and to inform dialogue and action among stakeholders. Data can be used to identify the most important risk factors to target and gaps in care in order to identify and impleme...
Reporting Period 2010-2011
The information provided here can be used to understand the current situation, increase attention to preterm births in Rwanda and to inform dialogue and action among stakeholders. Data can be used to identify the most important risk factors to target and gaps in care in order to identify and impleme...
The information provided here can be used to understand the current situation, increase attention to preterm births in Rwanda and to inform dialogue and action among stakeholders. Data can be used to identify the most important risk factors to target and gaps in care in order to identify and impleme...
In contrast to bilateral aid, aid disbursed from
multilateral institutions increased significantly at the onset
of the COVID-19 pandemic. Yet, at a time when a coherent
and effective multilateral response is needed most, the
COVID-19 pandemic revealed a shifting landscape of donor
agencies that...
Africa’s health sector is facing an unprecedented financing crisis, driven by a sharp decline of 70% in Official Development Assistance (ODA) from 2021 to 2025 and deep-rooted structural vulnerabilities. This collapse is placing immense pressure on Africa’s already fragile health systems as ODA ...
Malaria in pregnancy is a significant health problem in malaria-endemic areas. It not only causes substantial childhood morbidity and mortality but also increases the risks of adverse events for pregnant women and their developing fetuses. Most of the burden in these areas is due to infection with P...
PLOS Glob Public Health 3(7): e0001132. https://doi.org/10.1371/journal.
pgph.0001132
This paper proposes a framework for strategic communications for malaria governance that involves five key elements: knowing the audience, defining the message, designing a medium, identifying a messenger, and ...
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends an offering long-acting injectable lenacapavir (LEN...
Safety and efficacy of long-acting injectable lenacapavir as pre-exposure prophylaxis to reduce the risk of HIV acquisition: a systematic review
recommended
New
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
A Rapid Appraisal of Priorities, Policies and Practices
